Re: ERBB2 amplification is superior to protein expression status in predicting patient outcome in serous ovarian carcinoma (92:31-39) by Lassus et al

Gynecol Oncol. 2004 Nov;95(2):416-7; author reply 417-8. doi: 10.1016/j.ygyno.2004.08.012.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Chromosomes, Human, Pair 17 / genetics
  • Cystadenocarcinoma, Serous / genetics*
  • Cystadenocarcinoma, Serous / metabolism
  • Female
  • Gene Amplification
  • Genes, erbB-2 / genetics
  • Humans
  • Ovarian Neoplasms / genetics*
  • Ovarian Neoplasms / metabolism
  • Receptor, ErbB-2 / biosynthesis
  • Receptor, ErbB-2 / genetics*

Substances

  • Receptor, ErbB-2